Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1AZD4017 and prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 75 💬
2Combination therapy with vigabatrin and prednisolone
(D00472)		[2] Prednisolone,
Vigabatrin		[2] Prednisolone (D00472),
Vigabatrin 💬		[2] ABAT,
NR3C1 💬		[8] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 145 💬
3Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
(D00472)		[7] Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		[6] Hydrocortisone ,
Dexamethasone ,
Prednisolone (D00472),
Prednisone ,
Cortisone acetate ,
Cortisone 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
4Corticosteroid treatment (Methylprednisolone or prednisolone)
(D00472)		[2] Methylprednisolone,
Prednisolone		[2] Methylprednisolone ,
Prednisolone (D00472) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 64 💬
5Corticosteroids (prednisone or prednisolone)
(D00472)		[2] Prednisolone,
Prednisone		[2] Prednisolone (D00472),
Prednisone 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
6Etanercept, Methotrexate, Prednisolone
(D00472)		[3] Etanercept,
Methotrexate,
Prednisolone		[3] Methotrexate ,
Prednisolone (D00472),
Etanercept 💬		[5] DHFR,
DHFR2,
LTA,
NR3C1,
TNF 💬		[72] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 56 💬
7Glucocorticoid (prednisone or prednisolone)
(D00472)		[2] Prednisolone,
Prednisone		[2] Prednisolone (D00472),
Prednisone 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
8Intravenous methyl prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 43 💬
9Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP
(D00472)		[5] Dapsone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone,
Triamcinolone		[5] Triamcinolone ,
Prednisolone (D00472),
Dapsone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬[1] 162 💬
10Lodotra (delayed release prednisolone)
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
11Long-circulating liposomal prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
12Low dose prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
13Medium dose prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
14Methotrexate - etanercept - prednisolone arm
(D00472)		[3] Etanercept,
Methotrexate,
Prednisolone		[3] Methotrexate ,
Prednisolone (D00472),
Etanercept 💬		[5] DHFR,
DHFR2,
LTA,
NR3C1,
TNF 💬		[72] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 46, 107 💬
15Methyl prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 43, 49, 96 💬
16Methylprednisolone or Prednisolone
(D00472)		[2] Methylprednisolone,
Prednisolone		[2] Methylprednisolone ,
Prednisolone (D00472) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
17Oral prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 49, 96, 145 💬
18Overencapsulated Prednisolone Tablets
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
19Paroxetine & Prednisolone
(D00472)		[2] Paroxetine,
Prednisolone		[2] Prednisolone (D00472),
Paroxetine 💬		[2] NR3C1,
SLC6A4 💬		[3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46 💬
20Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP
(D00472)		[2] Paroxetine,
Prednisolone		[2] Prednisolone (D00472),
Paroxetine 💬		[2] NR3C1,
SLC6A4 💬		[3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46 💬
21Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP
(D00472)		[2] Paroxetine,
Prednisolone		[2] Prednisolone (D00472),
Paroxetine 💬		[2] NR3C1,
SLC6A4 💬		[3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46 💬
22PEG-liposomal Prednisolone Sodium Phosphate
(D00472)		[2] Phosphate ion,
Prednisolone		[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 13, 97 💬
23Prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[42] 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
24Prednisolone & dipyridamole
(D00472)		[2] Dipyridamole,
Prednisolone		[2] Dipyridamole ,
Prednisolone (D00472) 💬		[3] NR3C1,
PDE4A,
PDE5A 💬		[7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 46 💬
25Prednisolone + mabthera
(D00472)		[2] Prednisolone,
Rituximab		[2] Prednisolone (D00472),
Rituximab 💬		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 61 💬
26Prednisolone 1mg Tablets
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
27Prednisolone 2,5 mg Tablets
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
28Prednisolone 20 mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
29Prednisolone 40 mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
30Prednisolone 5 mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 46, 51 💬
31Prednisolone 5 mg JENAPHARM
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
32Prednisolone 5 mg Tablets
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
33Prednisolone 5mg Gastro-resistant Tablets
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 51 💬
34Prednisolone 5mg Tablet
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
35PREDNISOLONE ACETATE
(D00472)		[3] Acetate,
Prednisolone,
Prednisolone acetate		[2] Prednisolone (D00472),
Prednisolone acetate 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
36Prednisolone and chlorambucil
(D00472)		[2] Chlorambucil,
Prednisolone		[2] Chlorambucil ,
Prednisolone (D00472) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
37Prednisolone and mycophenolate mofetil
(D00472)		[3] Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone		[3] Prednisolone (D00472),
Mycophenolate mofetil ,
Mycophenolic acid 💬		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬[1] 222 💬
38Prednisolone and taper
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 51 💬
39Prednisolone Labesfal
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
40Prednisolone sodium metasulphobenzoate
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
41PREDNISOLONE SODIUM PHOSPHATE
(D00472)		[2] Phosphate ion,
Prednisolone		[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 3, 13, 97 💬
42PREDNISOLONE SODIUM SUCCINATE
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 95 💬
43Prednisolone Tablets B.P. 5mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
44Prednisolone Tablets BP
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
45Prednisolone Tablets BP 1 mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
46Prednisolone Tablets USP 5 mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
47Prednisolone-Dipyridamole
(D00472)		[2] Dipyridamole,
Prednisolone		[2] Dipyridamole ,
Prednisolone (D00472) 💬		[3] NR3C1,
PDE4A,
PDE5A 💬		[7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 46 💬
48Prednisolone/Prednisone
(D00472)		[2] Prednisolone,
Prednisone		[2] Prednisolone (D00472),
Prednisone 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
49Prednisone or Prednisolone
(D00472)		[2] Prednisolone,
Prednisone		[2] Prednisolone (D00472),
Prednisone 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 66, 84 💬
50Prednisone/Prednisolone
(D00472)		[2] Prednisolone,
Prednisone		[2] Prednisolone (D00472),
Prednisone 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 35 💬
51Pyridoxine plus prednisolone
(D00472)		[2] Prednisolone,
Pyridoxine		[2] Prednisolone (D00472),
Pyridoxine 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 145 💬
52SOLUBLE PREDNISOLONE TABLETS
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 145 💬
53Trexan+Salazopyrin+Oxiklorin+prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
54Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab
(D00472)		[2] Infliximab,
Prednisolone		[2] Prednisolone (D00472),
Infliximab 💬		[2] NR3C1,
TNF 💬		[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
55Z102 (Prednisolone and Dipyridamole).
(D00472)		[2] Dipyridamole,
Prednisolone		[2] Dipyridamole ,
Prednisolone (D00472) 💬		[3] NR3C1,
PDE4A,
PDE5A 💬		[7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 46 💬